Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse

Psychopharmacology

Volumn 217, Issue 1, 2011, Pages 3-12

  Lynch, Wendy J ^a   Bond, Colin ^a   Breslin, Florence J ^a   Johnson, Bankole A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alcohol; Alcohol consumption; Alcohol deprivation effect; Combination treatment; Consumption; Endophenotype; Ethanol; Ondansetron; Rats; Topiramate

Indexed keywords

ONDANSETRON; TOPIRAMATE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG MECHANISM; MALE; MONOTHERAPY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PREDICTOR VARIABLE; PRIORITY JOURNAL; RAT; RELAPSE; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ETHANOL; FRUCTOSE; GABA MODULATORS; MALE; ONDANSETRON; RATS; RATS, WISTAR; RECURRENCE; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 82955236188     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2253-0     Document Type: Article

References (37)

1. Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ (2006) The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addiction Biol 11(3-4):270-288 (Pubitemid 46696904)
2. Booth BM, Yates WR, Petty F, Brown K (1991) Patient factors predicting early alcohol-related admissions for alcoholics: role of alcoholism severity and psychiatric co-morbidity. J Stud Alcohol 52:37-43
3. Breslin FJ, Johnson BA, Lynch WJ (2010) Effect of topiramate treatment on ethanol consumption in rats. Psychopharmacology 207(4):529-534
4. Cagetti E, Baicy KJ, Olsen RW (2004) Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. NeuroReport 15:207-210 (Pubitemid 41615000)
5. Campbell AD, McBride WJ (1995) Serotonin-3 receptor and ethanolstimulated dopamine release in the nucleus accumbens. Pharmacol Biochem Behav 51(4):835-842
6. Curigliano G, Rigo R, Colleoni M, Braud FD, Nole F, Formica V, Orlando L, Cinieri S, Torrisi R, Cardillo A, Peruzzotti G,MediciM, Ardito R, Minchella I, Goldhirsch A (2004) Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features. Clin Breast Cancer 5(2):125-130 (Pubitemid 39029204)
7. De Deurwaerdere P, Moison D, Navailles S, Porras G, Spampinato U (2005) Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens. J Neurochem 94(1):140-149 (Pubitemid 40911400)
8. Hargreaves GA, McGregor IS (2007) Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res 31(11):1900-1907 (Pubitemid 47609640)
9. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatr 64(7):830-842 (Pubitemid 47026379)
10. Higgins GA, Tomkins DM, Fletcher PJ, Sellers EM (1992) Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system. Neurosci Biobehav Rev 16(4):535-552
11. Hightower D (2006) Cancer diagnostics: informing the development of tailored cancer therapy. In Benchmarks 6(3). National Cancer Institute, http://www.cancer.gov/newscenter/benchmarks-vol6-issue3/page1
12. Hobson K (2009) The era of personalized medicine. In the eyes of Edward Abrahams, treatments should be tailored like suits. US News World Rep 146(7):35
13. Johnson BA (2004a) Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-ofconcept study. Alcohol Clin Exp Res 28(8):1137-1144. (Pubitemid 39108611)
14. Johnson BA (2004b) Topiramate-induced neuromodulation of corticomesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence? Addiction Behav 29 (7):1465-1479 (Pubitemid 39165999)
15. Johnson BA (2004c) Uses of topiramate in the treatment of alcohol dependence. Expert Rev Neurother 4(5):751-758 (Pubitemid 39186680)
16. Johnson BA (2005) Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 19 (10):873-896 (Pubitemid 43138337)
17. Johnson BA (2008) Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75(1):34-56 (Pubitemid 350235398)
18. Johnson BA (2010) Medication treatment of different types of alcoholism. Am J Psychiatr 167(6):630-639
19. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 284(8):963-971 (Pubitemid 30659126)
20. Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002) Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology 160(4):408-413 (Pubitemid 34253283)
21. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361(9370):1677-1685 (Pubitemid 36577440)
22. Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ (2004) Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatr 61(9):905-912 (Pubitemid 39181080)
23. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. JAMA 298(14):1641-1651
24. Kapasova Z, Szumlinski KK (2008) Strain differences in alcoholinduced neurochemical plasticity: a role for accumbens glutamate in alcohol intake. Alcohol Clin Exp Res 32(4):617-631 (Pubitemid 351430429)
25. Knapp DJ, Pohorecky LA (1992) Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats. Pharmacol Biochem Behav 41(4):847-850
26. Knapp CM, Mercado M, Markley TL, Crosby S, Ciraulo DA, Kornetsky C (2007) Zonisamide decreases ethanol intake in rats and mice. Pharmacol Biochem Behav 87(1):65-72 (Pubitemid 46855820)
27. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13(5):177-184
28. Kostowski W, Bisaga A, Jankowska E, Krzaścik P (1994) Studies on the effects of certain 5-HT-3 receptor antagonists on ethanol preference and withdrawal seizures in the rat. Pol J Pharmacol 46 (3):133-137 (Pubitemid 24250436)
29. Lovinger DM (1997) Serotonin"s role in alcohol"s effects on the brain. Alcohol Health Res World 21(2):114-120 (Pubitemid 127709489)
30. McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12(4):339-369 (Pubitemid 29073864)
31. McBride WJ, Murphy JM, Lumeng L, Li TK (1990) Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 7(3):199-205 (Pubitemid 20268902)
32. McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM, Roache JD, Johnson BA (2004) Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcohol Clin Exp Res 28(2):257-267 (Pubitemid 38233603)
33. Mylecharane EJ (1996) Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies. Behav Brain Res 73(1.2):1-5 (Pubitemid 26008754)
34. Rodd ZA, Bell RL, Sable HJ, Murphy JM, McBride WJ (2004) Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav 79(3):439-450 (Pubitemid 39576161)
35. Rodd ZA, Bell RL, Oster SM, Toalston JE, Pommer TJ, McBride WJ, Murphy JM (2010) Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol selfadministration of alcohol-preferring (P) rats. Alcohol 44 (3):245-255
36. Schuckit MA (2009) Alcohol-use disorders. Lancet 373:492-501
37. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154(2):299-315 (Pubitemid 351670598)